CME Group insider William R. Shepard bought 1,407 shares on the open market on March 26, 2026, paying $297.38 per share for a total of about $418,650. Open-market buying matters to many investors because it typically reflects an insider choosing to put personal capital into the stock at the prevailing market price, rather than receiving shares through compensation or other arrangements. Shepard is listed as an insider, meaning he has access to internal information and is subject to trading restrictions and reporting rules. While the filing doesn’t explain his motivation, the size of the purchase is notable in dollar terms and stands out as a clear, voluntary buy. This purchase also comes shortly after a sizable sale by another insider, Jonathan L. Marcus, who sold 3,291 shares on March 17, 2026 for roughly $1.10 million at $333.37 per share. With only one reported CME insider transaction in the last 30 days (Shepard’s buy), there isn’t a broader cluster of insider activity to compare. Still, the recent mix of one large sale and one meaningful purchase shows insiders have not been acting in a single direction during March.